Zolasartan
Alternative Names: GR 117289Latest Information Update: 05 Sep 1995
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension